Lumentum vs Revolution Medicines Inc. Common Stock — how do they compare? Lumentum trades at $1,117.48 (market cap $94.99B), while Revolution Medicines Inc. Common Stock trades at $190.86 (market cap $40.32B). The key difference: Lumentum is far larger — about 2.4× Revolution Medicines Inc. Common Stock's market cap. Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| LITE | RVMD | |
|---|---|---|
Market Cap | $94.99B | $40.32B |
Volume | 4,855,776 | 4,855,734 |
Sector | Technology | Health |
52-Week High | $1.13K | $221.15 |
52-Week Low | $149.61 | $47.50 |
Typical Hold Time | 4 Days | 0 Days |
Enterprise Value | $93.92B | $37.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →